Clinical Trial

Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 9, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-14.
Status change: Not Yet Recruiting → Recruiting 2025-09-02
Trial Details
NCT Number NCT06643130
Lead Sponsor JW Pharmaceutical
Conditions Hypertension, Dyslipidemia
Enrollment 162 participants
Start Date 2024-12-02
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-09-09